NCCN Guidelines® Insights: Thyroid Carcinoma, Version 1.2025
Robert I. Haddad(Georgetown University), Bailee Sliker(National Comprehensive Cancer Network), Stephanie Markovina(Washington University in St. Louis), Dominick Lamonica(Dana-Farber Brigham Cancer Center), Jochen H. Lorch(Northwestern University), Lisle M. Nabell(Memorial Sloan Kettering Cancer Center), Rebecca S. Sippel(University of Wisconsin–Madison), Wojciech K. Mydlarz(Johns Hopkins University), Erik Blomain(Cancer Institute (WIA)), Maria Brito(Southwestern Medical Center), Victor Bernet, Carly J. Cassara(National Comprehensive Cancer Network), Francis P. Worden(Georgetown University), Theresa Guo(National Foundation for Cancer Research), Jennifer A. Sipos(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Cord Sturgeon(Northwestern University), Lori J. Wirth(Massachusetts General Hospital), Hadley E. Ritter(Indiana University Melvin and Bren Simon Comprehensive Cancer Center), Jatin P. Shah(Memorial Sloan Kettering Cancer Center), Megan R. Haymart(University of Michigan), Susan Darlow(National Comprehensive Cancer Network), Michael W. Yeh(University of California, Los Angeles), Naifa L. Busaidy(The University of Texas MD Anderson Cancer Center), Erin C. Grady(Cancer Institute (WIA)), Mara Y. Roth(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), John A. Ridge(Fox Chase Cancer Center), Richard J. Wong(Memorial Sloan Kettering Cancer Center), Rod Rezaee(Cleveland Clinic), Sarimar Agosto Salgado(Moffitt Cancer Center), Anupam Kotwal(Nebraska Medical Center), Randall P. Scheri(Duke University), Michael J. Campbell(UC Davis Comprehensive Cancer Center), Megan K. Applewhite(University of Chicago Medicine Comprehensive Cancer Center), Christopher D. Raeburn(University of Colorado Anschutz Medical Campus), Quan‐Yang Duh(UCSF Helen Diller Family Comprehensive Cancer Center), Hormoz Ehya(Fox Chase Cancer Center), Susan J. Mandel(University of Pennsylvania), Jason P. Hunt(University of Utah), Fouad Kandeel(City of Hope), Lindsay Bischoff(Breast Cancer Research Foundation), Olivia M. DeLozier(University of Tennessee Health Science Center)
Cited by 30
Related Papers
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
|New England Journal of Medicine|2007|1.7k
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2020|1.4k
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2021|1.1k